Edit

Check-Cap Ltd.

http://www.check-cap.com/

Last activity: 07.02.2022

Categories: 3DDevelopmentDiagnosticsEquipmentHardwareITManufacturingMedTechSoftwareTechnology

Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening through the introduction of C-Scan®, the first and only patient-friendly preparation-free screening test to detect precancerous polyps and enable early intervention and cancer prevention. The Company's disruptive capsule-based screening technology aims to significantly increase screening adherence worldwide and help millions of people to stay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon as it travels naturally along the gastrointestinal tract. C-Scan is non-invasive and requires no sedation. Unlike other capsule technologies, it requires no bowel preparation, allowing the patients to continue their daily routine with no interruption. Please view our notice Terms of Use here: https://check-cap.com/terms-of-use/

Followers

1.57K

Followers

2.94K

Website visits

16K /mo.

Mentions

Location: Israel, Haifa, Isfiya

Employees: 51-200

Total raised: $15.9M

Founded date: 2005

Twitter

Investors 3

Date	Name	Website
-	BXR Partne...	bxrgroup.c...
-	Intempo Ve...	intempo.ve...
-	Pontifax V...	pontifax.c...

Funding Rounds 2

Date	Series	Amount	Investors
28.02.2022	-	$10M	-
09.08.2016	-	$5.9M	-

Mentions in press and media 24

Date	Title	Description
07.02.2022	Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan	ISFIYA, Israel, Feb. 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and...
22.11.2021	Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®	ISFIYA, Israel, Nov. 22, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first an...
03.11.2021	Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update	ISFIYA, Israel, Nov. 3, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and...
02.11.2021	Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories	ISFIYA, Israel, Nov. 2, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and ...
30.10.2021	NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K/A	NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend the 2021 Annual General Meeting of Shareholders of Check-Cap Ltd. (the "Meeting") to be held on Thursday, December 2, 2021, ...
21.10.2021	Check Cap : NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend the 2021 Annual General Meeting of Shareholders of Check-Cap Ltd. (the "Meeting") to be held on Thursday, December 2, 2021, ...
18.10.2021	Check Cap : Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation	ISFIYA, Israel, Oct. 18, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first an...
05.08.2021	Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update	ISFIYA, Israel, Aug. 5, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and...
30.06.2021	Check-Cap Ltd. Announces $35 Million Registered Direct Offering USA - English USA - English
30.06.2021	Check-Cap Ltd. : Announces $35 Million Registered Direct Offering	ISFIYA, Israel, June 30, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first an...
12.05.2021	Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update	ISFIYA, Israel, May 12, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and...
19.03.2021	Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results	ISFIYA, Israel, March 19, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first a...
15.03.2021	Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®	ISFIYA, Israel, March 15, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan® , the first ...
15.03.2021	Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan® USA - English USA - English
27.01.2021	Check-Cap Issues Letter to Shareholders USA - English USA - English
02.09.2016	Digital health companies raised almost $224 million in August	Digital health funding in August So far this year, MobiHealthNews has tracked digital funding that has reached nearly $1.35 billion. August was a healthy month for funding, bringing in $223.86 million across 19 deals, putting it slightly ab...
09.08.2016	Check-Cap raises $5.9M to develop ingestible cancer-screening capsule	Israel-based Check-Cap, a clinical stage medical diagnostics company that is working on an ingestible sensor capsule to screen for colorectal cancer, has entered into an agreement with a single healthcare company for $5.9 million in financi...
04.08.2016	GE strikes 2nd collaboration with firm developing a colon-imaging capsule for prep-free colonoscopy	Check-Cap, an Israeli diagnostics company, is developing an ingestible capsule that is able to take X-ray images of the colon as it travels through a person’s body eliminating the elaborate prep needed. The company announced Thursday that i...
21.10.2014	Check-Cap Closes Financing	Check-Cap, Ltd., a Mount Carmel, Israel-based developer of a high-resolution imaging system for colorectal cancer screening, closed a financing round of undisclosed amount. The round was led by Fosun Pharma, a Chinese healthcare company, wi...
15.05.2012	GE $250M fund manager: We have a lot of dry powder, looking to invest	How much of the $250 million have you invested? For competitive reasons, we don’t disclose that, but we have a lot of dry powder. We’re more opportunity short than capital short, which is a great place to be in in this environment given som...
01.02.2012	Check-Cap Receives Investment from GE healthymagination Fund	Check-Cap, Ltd., a Mount Carmel, Israel-based medical device company focused on the development of gastrointestinal imaging devices, has received an investment from the GE healthymagination Fund. Check-Cap’s lead product is an endoscopy cap...
24.03.2011	Check-Cap Raises NIS35M	Check-Cap, a Mount Camel, Israel-based medical device company that is developing an innovative imaging capsule that uses X-rays for early detection of pre-cancerous polyps and colon cancer, has completed a NIS35m private funding. The compan...
-	GE $250M fund manager: We have a lot of dry powder, looking to invest	Startups, listen up. GE’s nearly two-and-a-half-year-old, $250 million Healthymagination Fund still has a “lot of dry powder” and executives are looking for promising startups to invest in. Noah Lewis, managing director of the Healthymagina...
-	GE strikes 2nd collaboration with firm developing a colon-imaging capsule for prep-free colonoscopy	Colonoscopy is an effective screening tool to detect polyps in the colon that could be cancerous. But the problem is that it requires significant prep work on the part of the patient — you have to drink a ton of liquids, clean out the gastr...

Check-Cap Ltd.

Investors 3

Funding Rounds 2

Mentions in press and media 24

Reviews 0